Sarıcı, A. And Tanrıverdi, L. H. 2023. MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?. Society of Hematologic Oncology 2023 Annual Meeting , (Texas, United States Of America), 384.

Sarıcı, A., & Tanrıverdi, L. H., (2023). MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose? . Society of Hematologic Oncology 2023 Annual Meeting (pp.384). Texas, United States Of America

Sarıcı, Ahmet, And LOKMAN HEKİM TANRIVERDİ. "MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?," Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 2023

Sarıcı, Ahmet And Tanrıverdi, LOKMAN H. . "MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?." Society of Hematologic Oncology 2023 Annual Meeting , Texas, United States Of America, pp.384, 2023

Sarıcı, A. And Tanrıverdi, L. H. (2023) . "MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?." Society of Hematologic Oncology 2023 Annual Meeting , Texas, United States Of America, p.384.

@conferencepaper{conferencepaper, author={Ahmet Sarıcı And author={LOKMAN HEKİM TANRIVERDİ}, title={MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?}, congress name={Society of Hematologic Oncology 2023 Annual Meeting}, city={Texas}, country={United States Of America}, year={2023}, pages={384} }